Morningstar® Stock Report™

Genscript Biotech Corp 01548

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten34,05%34,53%40,62%51,40%51,22%
Bruttogewinn65,95%65,47%59,38%48,60%48,78%
Vertriebsgemeinkosten45,95%50,58%59,19%56,07%46,19%
Forschung und Entwicklung68,05%67,39%70,13%62,35%51,56%
Umsatzrendite-45,14%-49,12%-68,14%-68,36%-47,53%
Net Int, Inc and Other-86,73%-121,25%-165,27%-137,36%-89,34%
EBIT Marge-41,59%-72,13%-97,13%-68,99%-41,81%
Ertragskraft
20192020202120222023
Steuersatz1,40%-0,12%0,90%-0,59%0,49%
Nettomarge-35,45%-52,44%-68,07%-36,26%-11,37%
Gesamtkapitalrendite-10,73-17,54-18,90-9,49-3,22
Financial Leverage2,321,612,542,522,44
Eigenkapitalsrendite-22,50-31,91-39,05-24,00-7,95